Elai Davicioni

27PUBLICATIONS
311CO-AUTHORS
Decision makingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 08, 2026
Multi-institutional Patient-level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence (MMAI) in Prostate Cancer.

|Jun 22, 2026
ERG Orchestrates a Dedifferentiation-Senescence-Inflammation Triad in Prostate Cancer.

|Mar 25, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.

Emmanuel S Antonarakis, Qing Cao, Victoria Catharine

|Feb 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

Ankur Malpani, Jonathan T Ryan, Hui Yu

|Oct 02, 2025
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence.

Anson T Ku, Uma Shankavaram, Shana Y Trostel

|Jul 15, 2025
Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy.

Joep J de Jong, Moritz J Reike, Yair Lotan

Pageof 5

Frequent Collaborators

5 joint publications

Daniel E Spratt

3 joint publications

Joep J de Jong

3 joint publications

Yang Liu

3 joint publications

James A Proudfoot